QT
TGTX icon

Quantamental Technologies’s TG Therapeutics TGTX Stock Holding History

Quantamental Technologies’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,900
Closed -$164K – 642
2023
Q1 		$164K Buy
+10,900
New +$166K 0.09% 360
2019
Q4 		– Sell
-9,550
Closed -$54K – 1252
2019
Q3 		$54K Buy
9,550
+8,144
+579% +$56.8K 0.02% 951
2019
Q2 		$12K Buy
+1,406
New +$10.6K ﹤0.01% 1225

Other funds holding TGTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Quantamental Technologies's TGTX Position: Q2 2023 in Review

Quantamental Technologies sold out of TG Therapeutics (TGTX) in Q2 2023, closing a stake of 10,900 shares — an estimated $164K sold.

Quantamental Technologies first reported a position in TGTX in Q2 2019 and held it in 3 quarters. The position peaked at $164K in Q1 2023. 244 funds tracked by Wall St. Rank hold TGTX as of Q2 2023.

  • Quantamental Technologies reported no remaining TG Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Quantamental Technologies sold 10,900 TG Therapeutics shares in Q2 2023, an estimated $164K.
  • Quantamental Technologies first reported a position in TG Therapeutics in Q2 2019 and held it in 3 quarters.
  • Quantamental Technologies's TG Therapeutics position peaked at $164K in Q1 2023.
  • 244 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2023.

Based on Quantamental Technologies's 13F filing for Q2 2023, filed 14 Aug 2023.